基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the complete record of transactions filed by LoPriore Vincent S. Insider active across 1 company, notably Hepion Pharmaceuticals, Inc.. In total, 4 reports have been recorded. Split: 4 buys · 0 sell. Total volume traded: €646k. Activity tracked since 21 April 2026. The latest transaction was disclosed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
LoPriore Vincent S is a declarant linked to Hepion Pharmaceuticals, Inc., where he is Executive Chairman. The 4 recorded filings concern acquisitions, with buys of EUR 646370 and no sales over the recent filing period, from 2026-04-27 to 2026-08-12.